Chemically modified gelatin as biomaterial in the design of new nanomedicines

Medicinal Chemistry

Volumn 7, Issue 3, 2011, Pages 145-154

  Lopez Cebral, Rita ^a   Martn Pastor M ^a   Evelin Parraga, Jenny ^a   Konat Zorzi, Giovanni ^a   Seijoa, Begoña ^a   Sanchez, Alejandro ^a  

^a UNIVERSITY OF SANTIAGO DE COMPOSTELA   (Spain)

Author keywords

Chemically modified protein; Gelatin; Gene delivery; Nanomedicines; Nanoparticles

Indexed keywords

ALPHA GELATIN; BETA GELATIN; BIOMATERIAL; BIOPOLYMER; DELTA GELATIN; ETHYLENEDIAMINE; FUNCTIONAL GROUP; GAMMA GELATIN; GELATIN; NANOPARTICLE; POLYAMINE; PROTEIN; SPERMINE; UNCLASSIFIED DRUG;

AMINO TERMINAL SEQUENCE; ARTICLE; CARBOXY TERMINAL SEQUENCE; CHEMICAL MODIFICATION; ISOELECTRIC POINT; MOLECULAR WEIGHT; MORPHOLOGY; NANOMEDICINE; PARTICLE SIZE; PHYSICAL CHEMISTRY; POTENTIOMETRY; PRIORITY JOURNAL; PROTEIN MODIFICATION; PROTON NUCLEAR MAGNETIC RESONANCE; SPECTROPHOTOMETRY; SYNTHESIS; ZETA POTENTIAL;

BIOCOMPATIBLE MATERIALS; DRUG DESIGN; ETHYLENEDIAMINES; GELATIN; NANOMEDICINE; NUCLEAR MAGNETIC RESONANCE, BIOMOLECULAR; SPERMINE;

EID: 79955757101     PISSN: 15734064     EISSN: None     Source Type: Journal    
DOI: 10.2174/157340611795564277     Document Type: Article

References (31)

1. Csaba, N.; Sánchez, A.; Alonso, M.J. PLGA: Poloxamer and PLGA: Poloxamine blend nanostructures as carriers for nasal gene delivery. J. Control. Release., 2006, 113(2), 164-172. (Pubitemid 43928142)
2. Raviña, M.; Paolicelli, P.; Seijo, B.; Sanchez, A. Knocking down gene expression with dendritic vectors. Mini. Rev. Med. Chem., 2010, 10, 73-86.
3. Petersen, L.B.; Jensen, T.G. Gene therapy for severe combined immunodeficiency. Ugeskr Læger., 2010, 172(23), 1756-1758.
4. Colonna, C.; Conti, B.; Perugini, P.; Pavanetto, F.; Modena, T.; Dorati, R.; Genta, I. Chitosan glutamate nanopartices for protein delivery: Development and effect on prolidase stability. J. Microencapsul., 2007, 24(6), 553-564. (Pubitemid 47180538)
5. Schmidt, J.J.; Rowley, J.; Kong, H.J. Hydrogels used for cell-based drug delivery. J. Biomed. Mater. Res. A., 87(4), 1113-1122.
6. de la Fuente, M.; Raviña, M.; Paolicelli, P.; Sanchez, A.; Seijo, B.; Alonso, M.J. Chitosan-based nanostructures: a delivery platform for ocular therapeutics. Adv. Drug Deliv. Rev., 2010, 62, 100-117.
7. Paolicelli, P.; de la Fuente, M.; Sánchez, A.: Seijo, B.; Alonso, M.J. Chitosan nanoparticles for drug delivery to the eye. Expert Opin. Drug Deliv., 2009, 6(3), 239-253.
8. d'Angelo, I.; Parajó, Y.; Horváth, A.; Kéri, G.; La Rotonda M.I.; Alonso, M.J. Improved delivery of angiogenesis inhibitors from PLGA:poloxamer blend micro- and nanoparticles. J. Microencapsul., 2010, 27, 57-66.
9. Cha, E.J.; Kim, J.E.; Ahn, C.H. Stabilized polymeric micelles by electrostatic interactions for drug delivery system. Eur. J. Pharm Sci., 2009, doi 10.1016/j.ejps.2009.08.006
10. Morille, M.; Passirani, C.; Vonarbourg, A.; Clavreul, A.; Benoit, J.P. Progress in developing cationic vectors for non-viral systemic gene therapy against cancer. Biomaterials., 2008, 29(24-25), 3477-3496.
11. Greindl, M.; Bernkop-Schnürch, A. Development of a Novel Method for the preparation of Thiolated Polyacrylic Acid anoparticles. Pharm. Res., 2006, 23(9): 2183-2189.
12. Kayser, O.; Lemke, A.; Hernández-Trejo, N. The impact of nanobiotechnology on the development of new drug delivery systems. Curr Pharm Biotechnol., 2005, 6, 3-5. (Pubitemid 40246748)
13. Walter N. G. Future of Biomedical Sciences: Single Molecule Microscopy. Biopolymers., 2007, 85(2), 103-105. (Pubitemid 46293991)
14. Baldwin, A. D.; Kiick K. L. 2010. Polysaccharide-modified synthetic polymeric biomaterials. Biopolymers., 2010, 94, 128-140.
15. Dong, W.; Han, B.; Feng, Y.; Song, F.; Chang, J.; Jiang, H.; Tang, Y.; Liu, W. Pharmacokinetics and biodegradation mechanisms of a versatile carboxymethyl derivative of chitosan in rats: in vivo and in vitro evaluation. Biomacromolecules., 2010, 11(6), 1527-1533.
16. Grenha, A.; Seijo, B.; Serra, C.; Remuñán-López, C. Surface characterization of lipid/chitosan nanoparticles assemblies, using X-ray photoelectron spectroscopy and time-of-flight secondary ion mass spectrometry. J. Nanosci. Nanotechnol., 2008, 8, 358-365. (Pubitemid 351594269)
17. Krishna O. D.; Kiick, K. L. Protein- and peptide-modified synthetic polymeric biomaterials. Biopolymers., 2010, 94, 32-48.
18. Fischer, D.; Bieber, T.; Brüsselbach, S.; Elsässer, H.; Kissel, T. Cationized human serum albumin as a non-viral vector system for gene delivery? Characterization of complex formation with plasmid DNA and transfection efficiency. Int. J. Pharm., 2001, 225(1-2), 97-111. (Pubitemid 32728203)
19. Melnyk, O.; Fehrentz, J. A.; Martinez, J.; Hélène, G. M. Functionalization of peptides and proteins by aldehyde or keto groups. Biopolymers., 2000, 55(2), 165-186. (Pubitemid 32002033)
20. Morimoto, K.; Chono, S.; Kosai, T.; Seki, T.; Tabata, Y. Design of cationic microspheres based on aminated gelatin for controlled re- lease of peptide and protein drugs. Drug Deliv., 2008, 15(2), 113-117. (Pubitemid 351302232)
21. Wu, D. H.; Chen, A. D.; Johnson, C. S. An Improved Diffusion- Ordered Spectroscopy Experiment Incorporating Bipolar-Gradient Pulses. J. Magn. Reson,. Ser. A., 1995, 115(2), 260-264.
22. Commission on Methods for Testing Photographic Gelatin. PAGI METHOD 10th ed. 2006.
23. Bubnis, W.A.; Ofner III C. M. The determination of A-amino groups in soluble and poorly soluble proteinaceous materials by a spectrophotometric method using trinitrobenzensulfonic acid. Anal. Biochem., 1992, 207, 129-133.
24. Seki, T.; Kanbayashi, H.; Nagao, T.; Chono, S.; Tabata, Y.; Morimoto, K. Effect of cationized gelatins on the paracellular transport of drugs through caco-2 cell monolayers. J. Pharm. Sci., 2006, 95(6), 1393-1401. (Pubitemid 43874453)
25. Kuijpers A. J.; Engbers G. H. M.; Feijen J.; De Smedt S. C.; Meyvis, T. K. L.; Demeester, J.; Krijgsveld J.; Zaat, S. A. J.; Dankert, J. Characterization of the network structure of carbodiimide crossLinked gelatin gels. Macromolecules., 1999, 32(10), 3325-3333.
26. Hitchcock, D. I. The isoelectric point of a standard gelatine preparation. J. Gen. Physiol., 1931, 14(6), 685-699.
27. Ward, A. G. The physical properties of gelatin solutions and gels. Br. J. Appl. Phys., 1954, 5(3), 85-90.
28. Rowe R. C.; Sheskey P. J.; Owen S. C. Handbook of pharmaceutical excipients. 5th ed. Ed. Pharmaceutical Press: London, UK, 2006; pp. 295- 298.
29. Mejillano, M. R.; Himes, R. H. Assembly properties of tubulin after carboxyl group modification. J. Biol. Chem., 1991, 266, 657-664. (Pubitemid 21906172)
30. Ofner III, C. M.; Bubnis, W. A. Chemical and swelling evaluations of amino group crosslinking in gelatine and modified gelatine matrices. Pharm. Res., 2004, 13(12), 1821-1827.
31. Wang, J.; Tabat, Y.; Bi, D.; Morimoto, K. Evaluation of gastric mucoadhesive properties of aminated gelatin microspheres. J. Control. Release. 2001, 73(2-3), 223-231. (Pubitemid 32539251)